Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients
暂无分享,去创建一个
[1] B. Loo,et al. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.
[2] R. Mamidanna,et al. Outcomes from chemoradiotherapy for patients with esophageal cancer. , 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[3] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[4] Roslyn J. Francis,et al. Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans , 2007, Journal of Nuclear Medicine.
[5] John L. Humm,et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[6] J. Reynolds,et al. Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus , 2010, The Journal of Nuclear Medicine.
[7] J. V. van Sandick,et al. Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer , 2014, Clinical nuclear medicine.
[8] Jin-Ching Lin,et al. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG‐PET/CT scan , 2015, Journal of the Chinese Medical Association : JCMA.
[9] Andre Dekker,et al. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer , 2013, Acta oncologica.
[10] J. Ajani,et al. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. , 2015, European journal of cancer.
[11] P. Dupont,et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. M. Kwee. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review. , 2010, Radiology.
[13] Soo Young Kim,et al. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. , 2007, European journal of cancer.
[14] Kyung Soo Lee,et al. Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications , 2010, Annals of Surgical Oncology.
[15] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[16] J. Siewert,et al. The importance of PET in the diagnosis and response evaluation of esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[17] Jinming Yu,et al. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. , 2011, Lung cancer.
[18] J. Luketich,et al. Oesophageal carcinoma , 2013, The Lancet.
[19] Jae Hyuk Lee,et al. The Predictive Role of Sequential FDG-PET/CT in Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation , 2012, American journal of clinical oncology.
[20] W. Huang,et al. Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non–Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy , 2014, The Journal of Nuclear Medicine.
[21] M. Stuschke,et al. Radiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trials. , 2012, Cancer treatment reviews.
[22] R. Boellaard,et al. Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer , 2011, Annals of surgery.
[23] P. Enzinger,et al. Esophageal cancer. , 2003, The New England journal of medicine.
[24] N. Meropol,et al. The Role of Qualitative and Quantitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response Following Chemoradiotherapy in Patients with Esophageal Carcinoma , 2012, Journal of Gastrointestinal Cancer.
[25] D. Rubello,et al. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. , 2006, AJR. American journal of roentgenology.
[26] J. Hatazawa,et al. Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG-PET) , 2014, Annals of Surgical Oncology.
[27] D. Huglo,et al. Ineffectiveness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Tumor Response After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer , 2013, Annals of surgery.
[28] J. Takita,et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma , 2005, Cancer.
[29] D. Rubello,et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. , 2009, International journal of radiation oncology, biology, physics.
[30] M. Kranzfelder,et al. Meta‐analysis of neoadjuvant treatment modalities and definitive non‐surgical therapy for oesophageal squamous cell cancer , 2011, The British journal of surgery.
[31] N. Holalkere,et al. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] D. Gotley,et al. Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[33] E W Steyerberg,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.
[34] Jeon Yeob Jang,et al. Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer , 2009, Clinical Cancer Research.